In this article we examine the two major classes of side effects with atypical antipsychotics:
extrapyramidal symptoms (EPS) and the metabolic syndrome (the triad of diabetes …

It has been 50 years since the first patients with tardive dyskinesia (TD) were described, but
the pathophysiology is only partially understood and effective treatments have remained …

Studies with first-episode populations offer the unique opportunity to examine the
effectiveness and side effects of medications without the confounding effects of prior …

The use of long-acting injectable antipsychotics (LAIs) in schizophrenia is usually restricted
to patients in long-term treatment, who prefer them to oral antipsychotics, and to patients with …

Chronic management of schizophrenia and schizoaffective disorders is frequently
complicated by symptomatic relapse. An open-label, randomized, active-controlled, 2-year …

A systematic and comprehensive literature search was performed to determine the extent of
weight gain induced by risperidone (RIS) treatment across the age span. The review and …

Background: Brexpiprazole has previously demonstrated efficacy in acute schizophrenia
trials. The objective of this trial was to assess the efficacy, safety, and tolerability of …

Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …

As with the two preceding guidelines of this series, these practice guidelines for the
pharmacological maintenance treatment of bipolar disorder were developed by an …

BACKGROUND: To optimize the management of patients with schizophrenia, quantification
of treatment effects is crucial. While in research studies, the use of quantitative assessments …